Monitoring Respiratory News Today : Breaking News, Live Updates & Top Stories | Vimarsana

As regulatory processes and reimbursements are refined, there needs to be a continued focus on how to maximize the benefits for patients and ensure DTx can play a role in improving outcomes. The key to this is integration into the clinical workflow.

Lung diseases are among the leading causes of death in the EU. Existing methods of chest disease analysis are expensive, uncomfortable, invasive, or use ionizing radiation.